Insulin and Pentacarinat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Insulin (insulin pork) and Pentacarinat (pentamidine isethionate). Common drug interactions include haematemesis among females and basal cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Insulin and Pentacarinat. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Insulin?

Insulin has active ingredients of insulin pork. It is often used in diabetes. eHealthMe is studying from 50,203 Insulin users. Check the latest studies of Insulin.

What is Pentacarinat?

Pentacarinat has active ingredients of pentamidine isethionate. eHealthMe is studying from 1,546 Pentacarinat users. Check the latest studies of Pentacarinat.



On Jul, 06, 2026

14 people who take Insulin and Pentacarinat together, and have interactions are studied.

Insulin and Pentacarinat drug interactions.

What are the common drug interactions of Insulin and Pentacarinat, by gender? *:

female:

  1. Haematemesis (vomiting of blood)
  2. Respiratory distress (difficulty in breathing)
  3. Viral infection
  4. Anaemia (lack of blood)
  5. Epstein-barr virus associated lymphoma (epstein-barr virus associated tumour)
  6. Immunosuppressant drug level increased
  7. Renal failure (kidney dysfunction)
  8. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  9. Aplasia (defective development or congenital absence of an organ or tissue)
  10. Discomfort

male:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  3. Diabetes mellitus inadequate control
  4. Metastatic squamous cell carcinoma (cancer of squamous cells spreads to other part)
  5. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  6. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  7. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)

What are the common drug interactions of Insulin and Pentacarinat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Aplasia (defective development or congenital absence of an organ or tissue)
  2. Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
  3. Respiratory distress (difficulty in breathing)
  4. Viral infection

20-29:

  1. Epstein-barr virus associated lymphoma (epstein-barr virus associated tumour)
  2. Immunosuppressant drug level increased
  3. Renal failure (kidney dysfunction)
  4. Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)
  5. Anaemia (lack of blood)

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  2. Squamous cell carcinoma (a cancer of a kind of epithelial cell)
  3. Diabetes mellitus inadequate control
  4. Metastatic squamous cell carcinoma (cancer of squamous cells spreads to other part)
  5. Discomfort
  6. Haematemesis (vomiting of blood)
  7. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
  8. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  9. Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)

What are the existing conditions these people have? *

  1. High Blood Pressure: 9 people, 64.29%
  2. Heart Attack: 7 people, 50.00%
  3. Dyslipidaemia (abnormal amount of lipids): 7 people, 50.00%
  4. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 50.00%
  5. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 2 people, 14.29%
  6. Thrombocytopenia (decrease of platelets in blood): 2 people, 14.29%
  7. Hypertensive Crisis: 2 people, 14.29%
  8. Hyperglycemia (high blood sugar): 2 people, 14.29%
  9. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 14.29%
  10. Sleep Disorder: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Insulin and Pentacarinat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Insulin and Pentacarinat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Insulin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pentacarinat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Insulin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pentacarinat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin pork and pentamidine isethionate (the active ingredients of Insulin and Pentacarinat, respectively), and Insulin and Pentacarinat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: